CytomX Therapeutics - 53 Year Dividend History | CTMX
Historical dividend payout and yield for CytomX Therapeutics (CTMX) since 1971. The current TTM dividend payout for CytomX Therapeutics (CTMX) as of December 20, 2024 is $0.00. The current dividend yield for CytomX Therapeutics as of December 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.087B |
$0.101B |
|
CytomX Therapeutics, Inc. is an oncology focused biopharmaceutical company. The Company is engaged in developing Probody(TM) therapeutics for the treatment of cancer. Its pipeline focuses areas consist of Precision cancer immunotherapy and Probody drug conjugates. CytomX Therapeutics, Inc. is headquartered in South San Francisco, California.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
